Peroxisome proliferator-activated receptor γ ligands and atherosclerosis:: ending the heartache

被引:54
作者
Rosen, ED
Spiegelman, BM
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
关键词
D O I
10.1172/JCI10909
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:629 / 631
页数:3
相关论文
共 32 条
  • [1] Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene
    Arai, T
    Wang, N
    Bezouevski, M
    Welch, C
    Tall, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 2366 - 2371
  • [2] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
  • [3] Berkowitz R, 1996, DIABETES, V45, P1572
  • [4] A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat
    Brown, KK
    Henke, BR
    Blanchard, SG
    Cobb, JE
    Mook, R
    Kaldor, I
    Kliewer, SA
    Lehmann, JM
    Lenhard, JM
    Harrington, WW
    Novak, PJ
    Faison, W
    Binz, JG
    Hashim, MA
    Oliver, WO
    Brown, HR
    Parks, DJ
    Plunket, KD
    Tong, WQ
    Menius, JA
    Adkison, K
    Noble, SA
    Willson, TM
    [J]. DIABETES, 1999, 48 (07) : 1415 - 1424
  • [5] The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
    Dunaif, A
    Scott, D
    Finegood, D
    Quintana, B
    Whitcomb, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) : 3299 - 3306
  • [6] Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
    Febbraio, M
    Podrez, EA
    Smith, JD
    Hajjar, DP
    Hazen, SL
    Hoff, HF
    Sharma, K
    Silverstein, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) : 1049 - 1056
  • [7] Insulin resistance and cardiovascular disease
    Ginsberg, HN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) : 453 - 458
  • [8] GINSBERG HN, 1998, LANCET, V352, P837
  • [9] GINSBERG HN, 1998, LANCET, V354, P602
  • [10] The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II
    Hattori, Y
    Akimoto, K
    Kasai, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) : 1144 - 1149